March 2024 in “Clinical, Cosmetic and Investigational Dermatology” Among Saudi dermatologists, this study reported widespread recognition of low-dose oral minoxidil's use for patterned hair loss and its side effect of hypertrichosis; however, many avoid prescribing it due to its unavailability in local pharmacies.
April 2024 in “Clinical, cosmetic and investigational dermatology” In this study, a survey of 84 Saudi Arabian dermatologists found increasing use of low-dose oral Minoxidil for hair loss management, though the limited sample size and English questionnaire may affect how well the findings represent the entire dermatologist population in the country.
June 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This study found that while 68% of adults were aware of minoxidil, only 42% had adequate knowledge of its proper use, with common side effects like scalp irritation and improper application frequently reported.
June 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This study observed that although 68% of the participants were aware of minoxidil, only 42% had proper knowledge of its correct use, with common misuse leading to scalp irritation and unwanted facial hair; highlighting the need for educational interventions for safer usage.
1 citations
,
September 2022 in “JAAD international” This study found that watching educational videos from a social media video library significantly improved patients' knowledge of hair loss disorders.
5 citations
,
April 2023 in “Drug Design Development and Therapy” This article discusses the increasing trend of retargeting existing drugs for new indications and emphasizes the need for additional support in drug development, without reporting specific new results.
This article discusses conventional and alternative treatments for hair loss but presents no new findings, highlighting concerns about the unknown long-term effects of approved drugs.
December 2022 in “Journal of Education, Health and Sport” This review suggests that combining treatments such as oral supplements, topical minoxidil, and high-platelet plasma may be effective for addressing telogen effluvium after COVID-19 infection, which affects about 30% of patients.
103 citations
,
December 2011 in “Journal of the American Academy of Dermatology” This review discusses current knowledge and management strategies for chemotherapy-induced alopecia, highlighting the need for better research prioritization and providing patient support materials, but reports no new clinical results.
58 citations
,
September 2012 in “Dermatologic Clinics” This article reviews current knowledge on the causes, diagnosis, and medical treatments for androgenetic alopecia, particularly in men, and reports no new findings.
48 citations
,
February 2017 in “Journal of Cosmetic Dermatology” This proposal reviews current knowledge and suggests actions for managing chemotherapy‐induced alopecia but reports no new clinical results, highlighting the need for evidence‐based guidelines.
5 citations
,
February 2004 in “The New England Journal of Medicine” The book provides updated knowledge on hair disorders and new treatments for hair loss.
October 2021 in “Cosmoderma” This review summarizes existing knowledge on diffuse and patterned alopecia, emphasizing recent advancements in treatment beyond FDA-approved options, but it reports no new clinical findings.
June 2020 in “Medicina estética (Madrid)” This study compiles current scientific knowledge on female pattern hair loss for aesthetic physicians, but it does not present new clinical findings.
This review discusses current knowledge on pediatric androgenetic alopecia and reports no new clinical results, highlighting the potential usefulness of topical and oral minoxidil, and topical finasteride.
1 citations
,
March 2025 in “Biomedical Journal of Scientific & Technical Research” This publication overview describes the Biomedical Journal of Scientific & Technical Research's rigorous peer review process and their focus on genetic, biomedical, and technical knowledge research within an open access format, but does not report specific study results.
June 2026 in “Current Opinion in Pediatrics” This study emphasized that trichoscopy and ultraviolet-enhanced follicular dermoscopy enhance diagnostic accuracy in adolescent alopecia, while systemic JAK inhibitors offer promising treatment options, reflecting the need for specialized, etiology-driven approaches and highlighting knowledge gaps in prevention and long-term outcomes.
November 2024 in “Open Repository of the University of Porto (University of Porto)” This report details a six-month internship experience, split between hospital and community pharmacy settings, which enhanced practical skills and theoretical knowledge in pharmaceutical care and highlighted the pharmacist's role in ensuring safe medication use.
11 citations
,
January 1980 in “Southern Medical Journal” This study found that minoxidil effectively manages various types of severe hypertension but can cause side effects such as sodium retention and tachycardia.
2 citations
,
January 2014 in “Hair therapy & transplantation” This study found that combining oral chelated Zinc with 5% minoxidil solution improved hair density and hair shaft diameter in women with female pattern hair loss, without reported side effects.
March 2020 in “Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature” In this study, eight Chinese patients with alopecia areata showed hair regrowth following combination therapy with a nonablative laser and topical minoxidil, with most patients not experiencing relapse after one year, suggesting a promising alternative treatment without significant side effects.
This study found that a once-daily capsule of minoxidil and spironolactone may safely reduce hair loss severity in women with female pattern hair loss.
5 citations
,
May 1994 in “Facial plastic surgery clinics of North America” This article reviews the clinical characterization and potential treatments for androgenetic alopecia, highlighting minoxidil's efficacy in hair regrowth and noting the need for further genetic research; it reports no new clinical results.
1 citations
,
January 2022 in “MedieKultur: Journal of Media and Communication Research” This article explores how YouTube videos of men using Minoxidil and Finasteride for hair growth redefine traditional roles of health experts and patients, offering a model applicable to various self-tracking communities.
November 2023 in “Australasian journal of dermatology” This review highlights the dermatological needs of transgender and gender diverse individuals in Australia, emphasizing the role of dermatologists in managing skin and hair conditions related to gender affirmation and hormone therapy.
105 citations
,
April 2004 in “Dermatologic Therapy” This review discusses medical and surgical therapies for alopecias in Black women, focusing on the impact of hair-care practices and the importance of patient education, but reports no new clinical results.
19 citations
,
November 2010 in “PubMed” This review discusses advancements in the genetic understanding of androgenic alopecia and the FDA-approved treatments, including a new laser hair comb, but reports no clinical results.
4 citations
,
April 2019 in “DOAJ (DOAJ: Directory of Open Access Journals)” This review highlights available treatments for frontal fibrosing alopecia, noting that 5-alpha reductase inhibitors, intralesional steroids, and hydroxychloroquine currently have the most evidence supporting their use, while other treatments show variable results and require further study.
4 citations
,
September 2011 in “Expert Review of Dermatology” This review discusses various treatment options for alopecia areata, noting a lack of consensus on grading and treatment algorithms, and reports no new clinical results.
Prescription and alternative therapies for hair loss will be compared for effectiveness.